Cargando…
Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmd(mdx) rat model
Duchenne Muscular Dystrophy (DMD) is a severe muscle-wasting disease caused by mutations in the DMD gene encoding dystrophin, expressed mainly in muscles but also in other tissues like retina and brain. Non-progressing cognitive dysfunction occurs in 20 to 50% of DMD patients. Furthermore, loss of e...
Autores principales: | Caudal, Dorian, François, Virginie, Lafoux, Aude, Ledevin, Mireille, Anegon, Ignacio, Le Guiner, Caroline, Larcher, Thibaut, Huchet, Corinne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065776/ https://www.ncbi.nlm.nih.gov/pubmed/32160266 http://dx.doi.org/10.1371/journal.pone.0230083 |
Ejemplares similares
-
Characterization of Dystrophin Deficient Rats: A New Model for Duchenne Muscular Dystrophy
por: Larcher, Thibaut, et al.
Publicado: (2014) -
TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD
por: Creisméas, Anna, et al.
Publicado: (2021) -
Evaluation of an AAV9-mini-dystrophin gene therapy candidate in a rat model of Duchenne muscular dystrophy
por: Le Guiner, Caroline, et al.
Publicado: (2023) -
Increased Neointimal Thickening in Dystrophin-Deficient mdx Mice
por: Rauch, Uwe, et al.
Publicado: (2012) -
Successful histocompatible myoblast transplantation in dystrophin- deficient mdx mouse despite the production of antibodies against dystrophin
Publicado: (1995)